Evaluation of Caries Prevention Based on Genetic Etiology and Risk.

NCT05600517 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2022-10-31

No results posted yet for this study

Summary

Dental caries affects billions of people worldwide and involves saliva immunodeficiency, commensal pathogen and exposure (lifestyle) causal subtypes of the disease. Up to 85% of adolescents in Swedish and other low prevalence populations are caries-free while the remaining 15% show high, recurrent caries activity. Accordingly, there is a lack of cost-effective risk assessment and prevention tools for personalized oral care. This randomized adaptive clinical trial (RCT) evaluates both caries prevention based on genetic etiology and risk, as a consequence of saliva immunodeficiency genes specifying individuals as susceptible or resistant to caries, and the effect of intensified versus selfcare traditional prevention on the two groups.

Conditions

  • Caries,Dental

Interventions

OTHER

Fluoride

a patient-centered education on diet, oral hygiene and fluoridated toothpaste 5000ppm with check up´s and topical fluoride application (varnish) every second month.

Sponsors & Collaborators

  • Vastra Gotaland Region

    collaborator OTHER_GOV
  • Region Västerbotten

    collaborator OTHER_GOV
  • Region Skane

    collaborator OTHER
  • Region Halland

    collaborator OTHER
  • Uppsala-Örebro Regional Research Council

    collaborator OTHER
  • Region Östergötland

    collaborator OTHER
  • Region Gävleborg

    collaborator OTHER
  • County Council of Norrbotten, Sweden

    collaborator OTHER_GOV
  • Västernorrland County Council, Sweden

    collaborator OTHER_GOV
  • The Swedish Research Council

    collaborator OTHER_GOV
  • Umeå University

    lead OTHER

Principal Investigators

  • Nicklas Stromberg, Prof · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-25
Primary Completion
2023-01-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05600517 on ClinicalTrials.gov